Objectivity & Balance. (a) The Grant Activity will be independent, non-promotional and free from commercial influence or bias.
(b) If the Grant Activity involves the discussion of Novartis products, or the comparison of Novartis products with other products, that discussion and/or comparison must be objective, balanced, accurate, not misleading or deceptive and in compliance with all applicable laws, rules and regulations. Where appropriate, the Grant Activity will include a discussion of multiple treatment options, and will not focus on a single product.
(c) Grant Recipient will ensure that any titles or overview information relating to the Grant Activity will fairly and accurately represent the scope of the planned activity.
(d) If required, Grant Recipient is responsible for selection of presenters, moderators and collaborators for the Grant Activity. Novartis will not control the planning, content, speaker selection or execution of any Grant Activity. If Novartis suggests presenters, moderators or collaborators, Grant Recipient will record the role of Novartis in making the suggestion, seek other sources and make a final selection based on balance and independence.
Objectivity & Balance. (a) The Sponsorship Activity will be independent, non-promotional and free from commercial influence or bias.
(b) If the Sponsorship Activity involves the discussion of Novartis products, or the comparison of Novartis products with other products, that discussion and/or comparison must be objective, balanced, accurate, not misleading or deceptive and in compliance with all applicable laws, rules and regulations. Where appropriate, the Sponsorship Activity will include a discussion of multiple treatment options, and will not focus on a single product.
(c) Sponsorship Recipient will ensure that any titles or overview information relating to the Sponsorship Activity will fairly and accurately represent the scope of the planned activity.
(d) If required, Sponsorship Recipient is responsible for selection of presenters, moderators and collaborators for the Sponsorship Activity. Novartis will not control the planning, content, speaker selection or execution of any Sponsorship Activity. If Novartis suggests presenters, moderators or collaborators, Sponsorship Recipient will record the role of Novartis in making the suggestion, seek other sources and make a final selection based on balance and independence.
Objectivity & Balance. The Accredited Provider will make every effort to ensure that data regarding the Commercial Interest's product(s) (or competing products) are objectively selected and presented by the activity faculty in the CME Activity, with favorable and unfavorable information and balanced discussion of prevailing information on the product(s) and/or alternative treatments. The Accredited Provider will ensure, to the extent possible, that the activity faculty makes meaningful disclosure of limitations on data, e.g., ongoing research, interim analyses, or unsupported opinion.
Objectivity & Balance. Sponsor will make every effort to ensure that data regarding the Commercial Supporter's products (or competing products) are objectively selected and presented, with favorable and unfavorable information and balanced discussion of prevailing information on the product(s) and/or alternative treatments.
Objectivity & Balance. Provider represents and warrants that:
(a) The content and format of the educational activity and its related materials will promote improvements or quality in healthcare and not the specific proprietary business interest of a commercial interest.
(b) The activity will give an objective and “balanced view,” which means that recommendation or emphasis must fairly represent, and be based on, a reasonable view and valid interpretation of the information available in the subject.
(c) The activity must present discussion of multiple treatment options, and shall not focus on a single product, except when options are so limited as to preclude meaningful discussion.
(d) If, in the Provider’s sole discretion, Lundbeck products are mentioned in the course of this activity, the Provider will make every effort to ensure that data regarding Lundbeck’s products (and competing products) are objectively selected and presented, with the favorable and unfavorable information and balanced discussion of prevailing information on the product(s) and/or alternative treatments.
(e) Generic names of products, rather than Brand names, shall be utilized for all products mentioned in the program.
(f) The title of the activity should fairly and accurately represented the scope of the presentation.
(g) Provider will ensure, to the extent possible, disclosure of limitations of data (e.g., ongoing research, interim analyses, preliminary data, or unsupported opinion(s)).
Objectivity & Balance. (a) If the Activity involves the discussion of Novartis products, or the comparison of Novartis products with other products, the discussion and/or comparison must be objective, balanced, accurate, not misleading or deceptive and in compliance with all applicable laws, rules and regulations. Where appropriate, the Activity will include a discussion of multiple treatment options, and will not focus on a single product.
(b) Recipient will ensure that any titles or overview information relating to the Activity will fairly and accurately represent the scope of the planned activity.
(c) If required, Recipient is responsible for selection of presenters, moderators and collaborators for the Activity. Novartis will not control the planning, content, speaker selection or execution of any Activity. If Novartis suggests presenters, moderators or collaborators, Recipient will record the role of Novartis in making the suggestion, seek other sources and make a final selection based on balance and independence.
Objectivity & Balance. The Peripheral Nerve Society will make every effort to ensure that data regarding the company's products (or competing products) are objectively selected and presented, with favorable and unfavorable information, and balanced discussion of prevailing information on the product(s) and/or alternative treatments.
Objectivity & Balance. The activity will be independent, non-promotional, and free from commercial influence or bias. If Lundbeck products are mentioned in the course of this activity, the Recipient will ensure that data regarding Lundbeck products (and competing products) are presented, with favorable and unfavorable information and balanced discussion of prevailing information on the product(s) and/or alternate treatments. The title of the activity will fairly and accurately represent the scope of the presentation. The activity will present discussion of multiple treatment options, and will not focus on a single product or therapy.
Objectivity & Balance. The accredited provider will make every effort to assure that data regarding the commercial interest’s products (or competing products) are objectively selected and presented with favorable and unfavorable information and balanced discussion of prevailing information on the product(s) and /or alternative treatments based on scientific evidence.
Objectivity & Balance. Accredited Provider and Joint Provider will make every effort to ensure that a balanced view of therapeutic options is given to the CME participants and that data regarding the company’s products (or competing products) are objectively selected and presented, with favorable and unfavorable information and balanced discussion of prevailing information on the product(s) and /or alternative treatments.
